Free Trial
Earnings Season Is Here. MarketBeat All Access for Just $149
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Get the Deal
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$102.61
-0.5%		$104.93
$81.97
▼
$132.02
$177.59B0.5911.24 million shs2.49 million shs
Dover Corporation stock logo
DOV
Dover
$206.95
+0.4%		$193.57
$176.40
▼
$237.54
$27.59B1.131.16 million shs813,414 shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover
The 7 Best High-Yield Dividend Stocks for 2027

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-1.43%+0.53%+1.87%-4.55%-18.82%
Dover Corporation stock logo
DOV
Dover
+1.87%+4.59%+7.48%+4.11%+15.90%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$102.61
-0.5%		$104.93
$81.97
▼
$132.02
$177.59B0.5911.24 million shs2.49 million shs
Dover Corporation stock logo
DOV
Dover
$206.95
+0.4%		$193.57
$176.40
▼
$237.54
$27.59B1.131.16 million shs813,414 shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover
The 7 Best High-Yield Dividend Stocks for 2027

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-1.43%+0.53%+1.87%-4.55%-18.82%
Dover Corporation stock logo
DOV
Dover
+1.87%+4.59%+7.48%+4.11%+15.90%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.89
Moderate Buy$118.3215.31% Upside
Dover Corporation stock logo
DOV
Dover
2.69
Moderate Buy$238.6015.29% Upside

Current Analyst Ratings Breakdown

Latest DOV and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/27/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Argus logo
Argus
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeBuy ➝ Hold
10/23/2026
Dover Corporation stock logo
DOV
Dover
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetSector Perform$216.00 ➝ $219.00
10/23/2026
Dover Corporation stock logo
DOV
Dover
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetBuy$266.00 ➝ $268.00
10/23/2026
Dover Corporation stock logo
DOV
Dover
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access to unlock brokerage rankings
Set Price Target$258.00
10/23/2026
Dover Corporation stock logo
DOV
Dover
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetOverweight$229.00 ➝ $233.00
10/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetBuy$125.00 ➝ $122.00
10/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetOutperform$130.00 ➝ $125.00
10/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetOverweight$112.00 ➝ $119.00
10/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetOverweight$120.00 ➝ $118.00
10/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetBuy$135.00 ➝ $118.00
10/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetBuy$134.00 ➝ $125.00
(Data available from 10/28/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$48.23B3.68$6.92 per share14.83$30.35 per share3.38
Dover Corporation stock logo
DOV
Dover
$8.58B3.21$12.91 per share16.03$53.99 per share3.83
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$2.6838.3017.251.829.75%17.97%9.22%N/A
Dover Corporation stock logo
DOV
Dover
$1.09B$8.5824.1817.781.7113.60%18.68%10.40%N/A

Latest DOV and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/22/2026Q3 2026
Dover Corporation stock logo
DOV
Dover
$2.85$2.88+$0.03$2.47$2.22 billion$2.23 billion
10/21/2026Q3 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.42$1.42N/A$0.53$12.99 billion$13.01 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.46%+10.39%94.03%54 Years
Dover Corporation stock logo
DOV
Dover
$2.101.01%+1.00%24.48%70 Years

Latest DOV and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/17/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.632.4%10/15/202610/15/202611/16/2026
8/7/2026
Dover Corporation stock logo
DOV
Dover
quarterly$0.52501.08%8/31/20268/31/20269/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.57
1.38
0.97
Dover Corporation stock logo
DOV
Dover
0.34
1.95
1.37

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Dover Corporation stock logo
DOV
Dover
84.46%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Dover Corporation stock logo
DOV
Dover
1.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.73 billion1.72 billionOptionable
Dover Corporation stock logo
DOV
Dover
24,000133.01 million131.55 millionOptionable

Recent News About These Companies

Dover (DOV) Reliance on International Sales: What Investors Need to Know
October 26 at 10:16 AM  |  zacks.comhttps://www.zacks.com/stock/news/3014698/dover-dov-reliance-on-international-sales-what-investors-need-to-know?cid=cs-stocknewsapi-ft-fundamental_analysis|nfm_international_revenues-3014698
Dover Corporation $DOV Stock Position Raised by Leeward Investments LLC MA
October 26 at 5:51 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-dover-corporation-dov-stock-position-raised-by-leeward-investments-llc-ma-2026-10-26/
Dover Commences Offers to Purchase for Cash Certain of Its Outstanding Debt Securities
October 26 at 4:45 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/26/3387855/0/en/dover-commences-offers-to-purchase-for-cash-certain-of-its-outstanding-debt-securities.html
Dover Corporation (NYSE:DOV) Stock Has Average Price Target of $237.93 According to Brokerages
October 25 at 3:29 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31154745
Dover Corporation $DOV Shares Acquired by Robeco Institutional Asset Management B.V.
October 24, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-dover-corporation-dov-shares-acquired-by-robeco-institutional-asset-management-bv-2026-10-24/
Dover Analysts Raise Their Forecasts Following Strong Q3 Earnings
October 23, 2026  |  benzinga.comhttps://www.benzinga.com/analyst-stock-ratings/price-target/26/10/62572827/dover-analysts-raise-their-forecasts-following-strong-q3-earnings?utm_source=snapi
Dover Corporation $DOV Stock Purchased by E. Ohman J or Asset Management AB
October 23, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-dover-corporation-dov-stock-purchased-by-e-ohman-j-or-asset-management-ab-2026-10-23/
Dover Corporation Signals Strong Growth and 2027 Upside
October 22, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/dover-corporation-signals-strong-growth-and-2027-upside?utm_source=marketbeat.com&utm_medium=referral
Dover Corporation (DOV) Q3 2026 Earnings Call Transcript
October 22, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4956500-dover-corporation-dov-q3-2026-earnings-call-transcript
Dover Q3 Earnings Beat on Broad Demand, Margins Improve
October 22, 2026  |  zacks.comhttps://www.zacks.com/stock/news/3013120/dover-q3-earnings-beat-on-broad-demand-margins-improve?cid=cs-stocknewsapi-ft-analyst_blog|earnings_article-3013120
Dover (DOV) Reports Q3 Earnings: What Key Metrics Have to Say
October 22, 2026  |  zacks.comhttps://www.zacks.com/stock/news/3012641/dover-dov-reports-q3-earnings-what-key-metrics-have-to-say?cid=cs-stocknewsapi-ft-fundamental_analysis|nfm-3012641
Dover Corporation 2026 Q3 - Results - Earnings Call Presentation
October 22, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4956411-dover-corporation-2026-q3-results-earnings-call-presentation
Dover Corporation (DOV) Beats Q3 Earnings and Revenue Estimates
October 22, 2026  |  zacks.comhttps://www.zacks.com/stock/news/3012428/dover-corporation-dov-beats-q3-earnings-and-revenue-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_4-3012428
Dover Reports Third Quarter 2026 Results
October 22, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/dover-reports-third-quarter-2026-results-302916126.html
26,298 Dover Corporation $DOV Shares Acquired by Vest Financial LLC
October 22, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-26298-dover-corporation-dov-shares-acquired-by-vest-financial-llc-2026-10-22/
CPC Launches DripFree Connectors for Cleaner, More Efficient Printing Processes
October 21, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/cpc-launches-dripfree-connectors-for-cleaner-more-efficient-printing-processes-302915703.html
14,624 Dover Corporation $DOV Shares Acquired by TD Waterhouse Canada Inc.
October 21, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-14624-dover-corporation-dov-shares-acquired-by-td-waterhouse-canada-inc-2026-10-21/
Unlocking Q3 Potential of Dover (DOV): Exploring Wall Street Estimates for Key Metrics
October 20, 2026  |  zacks.comhttps://www.zacks.com/stock/news/3010989/unlocking-q3-potential-of-dover-dov-exploring-wall-street-estimates-for-key-metrics?cid=cs-stocknewsapi-ft-fundamental_analysis|nfm_preview-3010989
Rising Income Over Big Yields: 4 Dividend Kings That Have Raised Payouts for 70 Years Straight
October 20, 2026  |  247wallst.comhttps://247wallst.com/investing/2026/10/20/rising-income-over-big-yields-4-dividend-kings-that-have-raised-payouts-for-70-years-straight/?utm_source=snapi
Dover Corporation (NYSE:DOV) Stock Has Consensus Target Price of $237.93 According to Brokerages
October 20, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-dover-corporation-nyse-dov-stock-has-consensus-target-price-of-23793-according-to-brokerages-2026-10-20/
15,860 Dover Corporation $DOV Shares Bought by Vontobel Holding Ltd.
October 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-15860-dover-corporation-dov-shares-bought-by-vontobel-holding-ltd-2026-10-18/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Illuminated Nike swoosh logo on a wall above a display pedestal with sneakers in a retail store.
Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam?
By Thomas Hughes | October 4, 2026
Kalshi and Polymarket logos beside a smartphone showing a prediction market on the Chiefs winning the Super Bowl, with a football in the background.
Want Private-Market Access to Kalshi and Polymarket? Try This ETF
By Jessica Mitacek | October 8, 2026
Close-up of an Nvidia logo on a computer chip mounted on a circuit board with cables and hardware components.
NVIDIA Just Strengthened the Case for Its Massive Stock Price Upside
By Thomas Hughes | September 29, 2026
Digital screen displays a red candlestick stock chart trending downward, illustrating a declining market against a city skyline.
3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a Dip
By Dan Schmidt | October 11, 2026
Branded box, container, syringe applicator, and sealed packets with a CP logo displayed on a bathroom counter.
Cologuard Is Working—So Why Isn’t Abbott Stock?
By Chris Markoch | October 22, 2026
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$102.61 -0.49 (-0.48%)
As of 02:57 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Dover stock logo

Dover NYSE:DOV

$206.95 +0.77 (+0.37%)
As of 02:57 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Dover Corporation provides equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services worldwide. The company's Engineered Products segment provides various equipment, component, software, solution, and services that are used in vehicle aftermarket, waste handling, industrial automation, aerospace and defense, industrial winch and hoist, and fluid dispensing end-market. This segment offers manual and power clamp, rotary and linear mechanical indexer, conveyor, pick and place unit, glove port, and manipulator, as well as end-of-arm robotic gripper, slide, and end effector; winches, hoists, bearings, drives, and electric monitoring system; and radio frequency and microwave filters and switches, and signal intelligence solutions. Its Clean Energy & Fueling segment offers component, equipment, and software and service solution enabling safe storage and transport of fuel, cryogenic gases, and hazardous fluids, as well as operation of retail fueling and vehicle wash establishment. The company's Imaging & Identification segment provides precision marking and coding, product traceability equipment, brand protection, and digital textile printing equipment and solution, as well as related consumable, software, and service to packaged and consumer goods, pharmaceutical, manufacturing, fashion and apparel, and other end-market. Its Pumps & Process Solutions segment manufactures specialty pump, connector, flow meter, fluid connecting solution, plastics and polymer processing equipment, and engineered components for rotating and reciprocating machines. The company's Climate & Sustainability Technologies segment manufactures refrigeration system, refrigeration display case, commercial glass refrigerator and freezer door, and brazed plate heat exchanger for industrial heating and cooling, and residential climate control applications. The company was incorporated in 1947 and is headquartered in Downers Grove, Illinois.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas